In brief
California has reported the first case in the US of a new mpox strain, Clade I, linked to recent travel to Africa. Despite historic severity, recent cases may not be clinically severe, underscoring the importance of vigilance and vaccination.
California has officially reported the first case of the Clade I strain of mpox, previously known as monkeypox, marking an alarming new development in the US amidst ongoing global health concerns. The California Department of Public Health (CDPH) confirmed the diagnosis following laboratory tests, noting that it is associated with an outbreak currently affecting Central and Eastern Africa. The patient, who has recently returned from Africa, is now isolating at home. The CDPH indicated that this case is directly connected to an upsurge of Clade I mpox, which has shown a propensity for more severe illness in the past. However, they emphasized that recent infections from this strain may not result in as severe symptoms as earlier outbreaks.Mpox is caused by a virus in the same family as smallpox but generally causes milder disease. Initially transmitted from animals to humans, it can now spread between individuals as well. Symptoms typically commence with fever, headaches, swollen lymph nodes, back pain, and muscle aches, eventually leading to a rash that may be very itchy or painful. Infections typically resolve on their own within 14 to 21 days; however, severe cases can occur, especially in vulnerable populations such as small children. Historically, mpox is most prevalent in remote villages in West and Central Africa, particularly in the Democratic Republic of Congo (DR Congo), where prior outbreaks resulted in significant fatalities. While outbreaks can be curtailed through vaccination efforts directed towards those at high risk, accessibility remains a challenge, with vaccines often limited to those who have come into close contact with confirmed cases. As health authorities monitor the situation, the emergence of this new strain highlights the necessity for global vigilance and a proactive approach to public health in light of promising yet unpredictable vaccine strategies.




